Hutch News

Stories tagged 'Vaccine and Infectious Disease Division (VIDD)'

Common cold can be surprisingly dangerous for transplant patients

Study shows typically ‘mild’ respiratory virus can turn into deadly pneumonia in this vulnerable population, points to need for effective meds, better prevention

March 7, 2017 | By Rachel Tompa / Fred Hutch News Service

The common cold is a major source of annoyance for most of us, but new research has found that for bone marrow transplant patients, this most common respiratory infection can be far worse than just a stuffy nose.

View story >


Open Science Prize goes to software tool for tracking viral outbreaks

Nextstrain wins international competition by making it easier to share, analyze genetic-sequencing data of spreading viruses

Feb. 28, 2017 | By Mary Engel / Fred Hutch News Service

After three rounds of competition — one of which involved a public vote — a software tool developed by researchers at Fred Hutchinson Cancer Research Center and the University of Basel to track Zika, Ebola and other viral disease outbreaks in real time has won the first-ever international Open Science Prize.

View story >


'We've become full partners'

An HIV laboratory in South Africa advances scientific understanding, and more

Jan. 6, 2017 | By Mary Engel / Fred Hutch News Service

Fred Hutch immunologist Dr. Erica Andersen-Nissen moved to Cape Town, South Africa, in 2013 to set up a state-of-the-art HIV laboratory to anchor two groundbreaking vaccine clinical trials. This is the story of building that lab, from the people up.

View story >


On the path to a new-generation malaria vaccine

New approach using genetically modified parasite ‘primes the immune system’ in first human trial

Jan. 4, 2017 | By Mary Engel / Fred Hutch News Service

Volunteers in a clinical trial led by Fred Hutch's Dr. Jim Kublin endured 150 to 200 mosquito bites in one 10-minute session to test a new approach to a malaria vaccine that uses genetically attenuated, or weakened, parasites to stimulate an immune response to malaria without causing disease.

View story >


'It's a great mission'

Partnering with Fred Hutch Global Oncology, Burkitt’s Lymphoma Fund for Africa carries on its founder’s passion

Dec. 23, 2016 | By Mary Engel / Fred Hutch News Service

Dr. Steve Kussick, president of the board for the Seattle-based Burkitt’s Lymphoma Fund for Africa, partners with Fred Hutch Global Oncology to bring cancer care to children in Uganda and Kenya.

View story >


A Q&A with Fred Hutch's Dr. Trevor Bedford

'Trying to be useful instead of trying to be clever': An evolutionary biologist-virologist-immunologist-computer-wonk finds his niche

Dec. 21, 2016 | By Mary Engel / Fred Hutch News Service

Fred Hutch's Dr. Trevor Bedford takes time away from figuring out how flu strains move around the world and wrangling Zika metadata to explain how he came to do what he does — and just what that entails.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.